Summary
This Global Burden of Disease Study 2021 systematically analysed the epidemiological burden of asthma and atopic dermatitis across 195 countries and territories from 1990 to 2021, integrating multi-source data to estimate disease prevalence, mortality, and disability impact. The analysis provides global and regional estimates stratified by demographic factors and extends projections to 2050 to inform health policy prioritisation and resource allocation in respiratory and dermatological disease management.
Regional applicability
As a global systematic analysis, findings are applicable to United Kingdom epidemiological surveillance and public health planning for asthma and atopic dermatitis. The study's country-level stratification permits comparison of United Kingdom burden trends against global and regional peers, supporting evidence-based allocation of National Health Service resources for these conditions.
Key measures
Disease prevalence, mortality, disability-adjusted life years (DALYs), stratified by age, sex, and sociodemographic index; burden projections to 2050
Outcomes reported
The study quantified the epidemiological burden of asthma and atopic dermatitis across 195 countries and territories from 1990 to 2021, including prevalence, mortality, and disability-adjusted life years (DALYs), with projections extended to 2050.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.